Market
GE HealthCare agrees to acquire SOFIE Biosciences in $945m deal
GE HealthCare has agreed to acquire SOFIE Biosciences, a PET radiopharmaceuticals contract manufacturer owned by Trilantic North America, for $945 million in a cash transaction expected to close in the first half of 2027. The deal expands GE HealthCare's radiopharmaceutical manufacturing and distribution capabilities.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network